Lobe Sciences Ltd.

Recent News

  • Lobe Announces Krysalis VX Innovations Inc., a Company Equally Owned by Lobe Sciences Ltd. and Virtual Psychedelics Incorporated, Appointment of Interdisciplinary Team of Advisors

    Vancouver, British Columbia--(Newsfile Corp. - October 6, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") today announced that Krysalis VX Innovations Inc. ("Krysalis"), the Virtual experience ("VX")-focused company designing the delivery of immersive, headset-free experiences through the KrysalisTM Pod system that will offer treatment options for cognitive, psychological, motor and functional impairments across various clinical health conditions, has appointed a distinguished and future-facing advisory team composed of Alex McDowell, Jon 9, Austin Blaisdell, and the...

    2021-10-06 8:45 AM EDT
  • Lobe Sciences to Present at the BioFuture 2021 & MoneyShow Virtual Expo Investor Conferences

    Vancouver, British Columbia--(Newsfile Corp. - October 5, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") today announced that Philip Young, CEO and Director, will present virtually at the BioFuture 2021 Conference taking place October 5-6, 2021, and will present virtually at the MoneyShow Virtual Expo taking place October 5-7, 2021Philip Young, CEO and Director, will have his presentation streamed throughout the conference at the Lobe virtual booth during the BioFuture 2021 Conference and will...

    2021-10-05 8:45 AM EDT
  • Lobe Sciences and the World Boxing Association Announce Initiative Targeting mTBI and PTSD

    Plans to Develop and Launch A Global Registry For The Identification and Long Term Management of Current and Former Boxers With mTBI and PTSDInsights Derived From This Project Will Help Guide The Development Of Guidelines and Treatment Goals For The WBA FamilyVancouver, British Columbia--(Newsfile Corp. - October 4, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce that the Company plans to develop and launch a global registry for the identification...

    2021-10-04 8:30 AM EDT
  • Lobe Sciences to Present at the Benzinga Healthcare Small Cap Conference

    Vancouver, British Columbia--(Newsfile Corp. - September 27, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") today announced that Philip Young, CEO and Director, will present virtually at the Benzinga Healthcare Small Cap Conference taking place September 29-30, 2021.Philip Young, CEO and Director will begin his presentation at 10:30 A.M. ET on Wednesday, September 29, 2021. The event is accessible using the following link: https://www.benzinga.com/events/small-cap/healthcare/september-29-track-1/.* * *About Lobe Sciences Ltd.Lobe Sciences is a life sciences...

    2021-09-27 8:45 AM EDT
  • Lobe Sciences to Participate at the Advances in Mental Health Psychedelics and Non-Psychedelics Conference

    Vancouver, British Columbia--(Newsfile Corp. - September 15, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") today announced that Philip Young, CEO and Director, will participate in a round table discussion at the Advances in Mental Health Psychedelics and Non-Psychedelics Conference presented by Maxim Group and hosed by M-Vest taking place Sept. 22, 2021.The discussion will focus on the topics surrounding Deliver, Manufacturing, & Technology and "What does it take to succeed in Psychedelics beyond...

    2021-09-15 9:02 AM EDT
  • Lobe Sciences Provides Corporate Update to Investors and Stakeholders

    Vancouver, British Columbia--(Newsfile Corp. - September 13, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to provide the following corporate update by CEO Philip Young, addressed to shareholders, investors and other stakeholders of the Company:Dear Fellow Shareholders and Psychedelic Medicine Enthusiasts,We are pleased to say that 2021 has been a busy and transformative year for the Company. During 2021, we have made significant progress on several fronts, and completed our transition to...

    2021-09-13 9:43 AM EDT
  • Lobe Sciences to Present At H.C. Wainwright 23rd Annual Global Investment Conference

    Vancouver, British Columbia--(Newsfile Corp. - September 10, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") today announced that Philip Young, CEO and Director, will present at the H.C. Wainwright 23rd Annual Global Investor Conference taking place Sept. 13-15, 2021.The presentation will be available on demand through the H.C. Wainwright conference portal, beginning at 7:00 a.m. ET on Monday, Sept. 13, 2021. Registration for the event is accessible via www.hcwevents.com/annualconference.The Company will also participate in one-on-one...

    2021-09-10 8:15 AM EDT
  • Lobe Sciences Appoints Albert "Skip" Rizzo, Ph.D to Scientific Advisory Board

    Director, Medical Virtual Reality - Institute for Creative Technologies Research Professor - Dept. of Psychiatry and School of Gerontology University of Southern CaliforniaVancouver, British Columbia--(Newsfile Corp. - August 23, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce the appointment of Albert "Skip" Rizzo, Ph.D, to its Scientific Advisory Board.Philip Young, CEO and Director of Lobe stated, "We are extremely happy to have an industry leading Virtual Reality (VR) expert joining...

    2021-08-23 8:45 AM EDT